This article is more than 5 years old. Information may no longer be current.
Bausch + Lomb to acquire Doctor’s Allergy Formula
Click Here to Manage Email Alerts
Bausch + Lomb has entered into a definitive agreement to acquire Doctor’s Allergy Formula LLC, which will be incorporated into the pharmaceuticals division, according to a press release.
“We are committed to delivering meaningful products to serve the needs of the eye care community and their patients, and Doctor’s Allergy Formula is just one example,” Tracy Valorie, senior vice president and general manager of Bausch + Lomb Pharmaceuticals, said in the release. “We congratulate the Doctor’s Allergy Formula team for identifying and successfully addressing this important area of unmet need and look forward to working with them to bring the benefits of this innovative diagnostic test to even more of our customers.”
The in-office diagnostic test lasts approximately 3 minutes and objectively diagnoses and identifies the cause of patients’ ocular allergies using a panel of 60 allergens that are specific to each region of the country. Results that determine ocular surface disease pathology and help in creating a customized treatment protocol are obtained within 15 minutes, the release said.